Recherche avancée

M. Fredric M. Ehlers est directeur de l'information chez Norfolk Southern Corp. et président de Railinc Corp. (Caroline du Nord). Il est membre du conseil d'administration de l'Alliance Theatre. Il a obtenu son diplôme de premier cycle à l'université d'État du Michigan et un MBA au Queens College.

Larry V.
Ehlers held former positions as Director of Information Technology & Operations at Quintessent Communications, Inc., Vice President of OSS & Applications at Eschelon Telecom, Inc., and Vice President of Applications at Securus Technologies LLC.
He obtained an undergraduate degree from Iowa State University.

Michael D.
Ehlers is the founder of Intergalactic Therapeutics, Inc. (founded in 2020) and holds the title of Chairman.
He is also the founder of Replicate Bioscience, Inc. Dr. Ehlers's current job(s) include being the Chief Executive Officer at Limelight Bio, Inc. since 2019, Chairman, President & Chief Executive Officer at Ascidian Therapeutics, Inc., Executive Chairman & Secretary at Aulos Bioscience, Inc., Director at The McKnight Endowment Fund for Neuroscience, Director at Nereid Therapeutics, Inc., Chief Scientific Officer & Venture Partner at Apple Tree Venture Management Llc since 2019, Board Member at Nine Square Therapeutics, Inc., and Board Member at Initial Therapeutics Inc. Dr. Ehlers's former jobs include being the Director of the Neuroproteomics Laboratory at Duke University, Senior Vice President and Head of BioTherapeutics R&D at Pfizer Inc., and Executive Vice President of Research & Development at Biogen, Inc. from 2016 to 2019.
Dr. Ehlers's education includes an undergraduate degree from the California Institute of Technology and graduate and doctorate degrees from The Johns Hopkins University School of Medicine.

Rick Ehlers was the Chairman of Walton International Group, Inc. He was also the Director of Canadian Broadcasting Corp.
from 1993 to 1999.
Additionally, he served as the Vice President-Human Resources at ENMAX Corp.